Johnson & Johnson the second-largest Pharmaceutical company have always been in debt. Around US $32 billion dollars ytd to be exact. debt isn't always a bad thing. But I agree product to market would be valuable at this stage of the cycle. I don't think it's fair to say they haven't delivered anything yet though.
Johnson & Johnson the second-largest Pharmaceutical company have...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.023(2.10%) |
Mkt cap ! $1.241B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $9.083M | 8.286M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 55559 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 175327 | 15 |
View Market Depth
| Last trade - 14.28pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.023 ( 0.92 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1469927 | ||
| Last updated 14.45pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |